Nair Lopes

912 total citations
18 papers, 722 citations indexed

About

Nair Lopes is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Nair Lopes has authored 18 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Nair Lopes's work include Cancer Cells and Metastasis (7 papers), Epigenetics and DNA Methylation (4 papers) and Estrogen and related hormone effects (3 papers). Nair Lopes is often cited by papers focused on Cancer Cells and Metastasis (7 papers), Epigenetics and DNA Methylation (4 papers) and Estrogen and related hormone effects (3 papers). Nair Lopes collaborates with scholars based in Portugal, Brazil and Norway. Nair Lopes's co-authors include Fernando Schmitt, Joana Paredes, Fernanda Milanezi, Bárbara Sousa, José Luís Costa, Madalena Gomes, Diana Martins, Daniella Serafin Couto Vieira, André Albergaria and Bauke Ylstra and has published in prestigious journals such as International Journal of Molecular Sciences, European Journal of Immunology and Human Pathology.

In The Last Decade

Nair Lopes

18 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nair Lopes Portugal 14 316 312 253 164 134 18 722
Madalena Gomes Portugal 11 172 0.5× 236 0.8× 239 0.9× 141 0.9× 102 0.8× 14 519
Shaham Beg Saudi Arabia 15 225 0.7× 204 0.7× 153 0.6× 114 0.7× 67 0.5× 37 517
Monika Migdalska‐Sęk Poland 17 265 0.8× 142 0.5× 87 0.3× 154 0.9× 57 0.4× 47 616
Pia Alhopuro Finland 14 438 1.4× 469 1.5× 429 1.7× 200 1.2× 91 0.7× 19 918
AA Colletta United Kingdom 9 282 0.9× 192 0.6× 69 0.3× 90 0.5× 191 1.4× 12 614
Handan Kaya Türkiye 16 146 0.5× 156 0.5× 150 0.6× 160 1.0× 32 0.2× 48 536
Akira Hirano Japan 12 220 0.7× 203 0.7× 97 0.4× 151 0.9× 102 0.8× 58 556
Allen M. Vukov United States 9 101 0.3× 511 1.6× 274 1.1× 145 0.9× 118 0.9× 9 847
D.M. Peehl United States 5 316 1.0× 186 0.6× 252 1.0× 198 1.2× 176 1.3× 6 762
Wioletta Pękala Poland 11 505 1.6× 192 0.6× 95 0.4× 230 1.4× 164 1.2× 15 689

Countries citing papers authored by Nair Lopes

Since Specialization
Citations

This map shows the geographic impact of Nair Lopes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nair Lopes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nair Lopes more than expected).

Fields of papers citing papers by Nair Lopes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nair Lopes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nair Lopes. The network helps show where Nair Lopes may publish in the future.

Co-authorship network of co-authors of Nair Lopes

This figure shows the co-authorship network connecting the top 25 collaborators of Nair Lopes. A scholar is included among the top collaborators of Nair Lopes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nair Lopes. Nair Lopes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Camilo, Vânia, et al.. (2021). Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines. Pharmaceuticals. 14(7). 670–670. 16 indexed citations
2.
Lopes, Nair, et al.. (2021). Hydralazine and Enzalutamide: Synergistic Partners against Prostate Cancer. Biomedicines. 9(8). 976–976. 11 indexed citations
3.
Salta, Sofia, Vera Miranda‐Gonçalves, Nair Lopes, et al.. (2020). A DNA methylation-based test for esophageal cancer detection. Biomarker Research. 8(1). 68–68. 14 indexed citations
4.
Lopes, Nair, Christian H. Bergsland, Jarle Bruun, et al.. (2020). A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis. Gastric Cancer. 23(5). 811–823. 22 indexed citations
5.
Lopes, Nair, Margareta P. Correia, Rui Henrique, & Cármen Jerónimo. (2020). Epigenetic Alterations in Oesophageal Cancer: Expression and Role of the Involved Enzymes. International Journal of Molecular Sciences. 21(10). 3522–3522. 8 indexed citations
6.
Lopes, Nair, Christian H. Bergsland, Merete Bjørnslett, et al.. (2019). Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2. Laboratory Investigation. 100(1). 120–134. 21 indexed citations
7.
Mesquita, Patrícia, Cristina Freire, Nair Lopes, et al.. (2019). Expression and Clinical Relevance of SOX9 in Gastric Cancer. Disease Markers. 2019. 1–11. 21 indexed citations
8.
Domingues, Rita G., Isabel Pereira‐Castro, Liliana Oliveira, et al.. (2016). CD5 expression is regulated during human T‐cell activation by alternative polyadenylation, PTBP1, and miR‐204. European Journal of Immunology. 46(6). 1490–1503. 32 indexed citations
9.
Sousa, Bárbara, Ana Sofia Ribeiro, Ana Rita Nobre, et al.. (2014). The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype. BMC Cancer. 14(1). 734–734. 23 indexed citations
10.
Lopes, Nair, Joana Carvalho, Cecília Durães, et al.. (2012). 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation.. PubMed. 32(1). 249–57. 67 indexed citations
11.
Lopes, Nair, Joana Paredes, José Luís Costa, Bauke Ylstra, & Fernando Schmitt. (2012). Vitamin D and the mammary gland: a review on its role in normal development and breast cancer. Breast Cancer Research. 14(3). 211–211. 55 indexed citations
12.
Martins, Diana, Bárbara Sousa, Nair Lopes, et al.. (2011). Molecular phenotypes of matched in situ and invasive components of breast carcinomas. Human Pathology. 42(10). 1438–1446. 9 indexed citations
14.
Sousa, Bárbara, Joana Paredes, Fernanda Milanezi, et al.. (2010). P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study.. PubMed. 25(8). 963–74. 42 indexed citations
15.
Albergaria, André, Joana Paredes, Bárbara Sousa, et al.. (2009). Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours. Breast Cancer Research. 11(3). R40–R40. 123 indexed citations
16.
Lopes, Nair, Bárbara Sousa, Daniella Serafin Couto Vieira, Fernanda Milanezi, & Fernando Schmitt. (2009). Vessel density assessed by endoglin expression in breast carcinomas with different expression profiles. Histopathology. 55(5). 594–599. 15 indexed citations
17.
Rodrigues, L. R., Nair Lopes, Bárbara Sousa, et al.. (2009). Significance of Osteopontin Expression in Human Invasive Breast Tumour Stroma. 1(1). 1–9. 7 indexed citations
18.
Paredes, Joana, Nair Lopes, Fernanda Milanezi, & Fernando Schmitt. (2006). P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 450(1). 73–80. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026